Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
09/12/202412:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
09/12/202412:30GlobeNewswire Inc.Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial DesignNASDAQ:VORVor Biopharma Inc
14/11/202421:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VORVor Biopharma Inc
12/11/202413:00GlobeNewswire Inc.Vor Bio to Participate in the Stifel 2024 Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
08/11/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/11/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/11/202421:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
07/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
05/11/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/11/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/10/202420:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/10/202420:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
30/09/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
30/09/202411:00GlobeNewswire Inc.Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial OfficerNASDAQ:VORVor Biopharma Inc
05/09/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
05/09/202420:01GlobeNewswire Inc.New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:VORVor Biopharma Inc
04/09/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
04/09/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
30/08/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
28/08/202412:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
08/08/202420:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/08/202420:13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:VORVor Biopharma Inc
08/08/202420:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
08/08/202420:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
05/08/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/08/202420:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
19/07/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VORVor Biopharma Inc
09/07/202420:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
10/06/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
04/06/202420:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR

Your Recent History